Radiation Syndrome

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2018-12-12
EMA Application withdrawn: Entolimod TMC (Entolimod) — TMC Pharma Services Ltd
The EMA withdrew the application for Entolimod (TMC) by TMC Pharma Services Ltd for Acute Radiation Syndrome.